Option Care Health, Inc. $OPCH Stake Lessened by Dimensional Fund Advisors LP

Key Points

• Dimensional Fund Advisors LP reduced its holdings in Option Care Health by 11.3%, owning 3,538,185 shares after selling 449,866 shares in the first quarter, which equates to approximately 2.16% of the company valued at $123.7 million.
• Option Care Health reported earnings per share of $0.41 for the latest quarter, exceeding analysts' estimates, and had revenues of $1.42 billion—up 15.4% year-over-year.
• Brokerages have set an average price target of $35.75 for OPCH shares, with multiple analysts rating the stock as a "Buy" or "Outperform."

Dimensional Fund Advisors LP cut its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 11.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,538,185 shares of the company's stock after selling 449,866 shares during the period. Dimensional Fund Advisors LP owned approximately 2.16% of Option Care Health worth $123,655,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of OPCH. Nuveen LLC acquired a new stake in shares of Option Care Health in the first quarter worth approximately $70,965,000. Allspring Global Investments Holdings LLC lifted its position in Option Care Health by 6,525,926.1% during the first quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock valued at $52,459,000 after buying an additional 1,500,963 shares in the last quarter. Voloridge Investment Management LLC acquired a new position in Option Care Health during the fourth quarter valued at approximately $27,428,000. Freestone Grove Partners LP acquired a new position in Option Care Health during the fourth quarter valued at approximately $17,487,000. Finally, Boston Partners acquired a new position in Option Care Health during the first quarter valued at approximately $24,353,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Stock Up 2.4%

Shares of NASDAQ OPCH traded up $0.67 during trading on Wednesday, reaching $28.59. 2,262,482 shares of the stock were exchanged, compared to its average volume of 1,935,419. The business's 50-day moving average price is $29.71 and its 200 day moving average price is $31.69. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The company has a market capitalization of $4.64 billion, a price-to-earnings ratio of 22.87, a price-to-earnings-growth ratio of 1.70 and a beta of 0.79.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.35 billion. During the same period in the previous year, the company posted $0.30 earnings per share. The business's revenue for the quarter was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, equities analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have weighed in on OPCH shares. Barrington Research reaffirmed an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Thursday, July 10th. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. JMP Securities lifted their price target on shares of Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. Finally, UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Eight investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Option Care Health presently has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Insiders Place Their Bets

In related news, Director Timothy P. Sullivan purchased 20,000 shares of the company's stock in a transaction that occurred on Thursday, August 21st. The stock was acquired at an average price of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the purchase, the director owned 49,229 shares in the company, valued at approximately $1,354,289.79. This represents a 68.43% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the company's stock in a transaction that occurred on Wednesday, August 20th. The stock was bought at an average price of $27.15 per share, with a total value of $977,400.00. Following the purchase, the director owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. The trade was a 10.61% increase in their position. The disclosure for this purchase can be found here. Insiders own 0.64% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.